ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, announced that Gary Rosenblum has been named President and Chief Executive Officer of ZEISS Vision Care US, effective June 16, 2025. Rosenblum brings relevant senior leadership experience at Demant, Johnson & Johnson, Abbott and Pfizer to his new role. He succeeds Jens Boy, who has spent more than a decade driving the ZEISS Vision Care business in North America, and will depart the company in pursuit of new opportunities on June 30, 2025.
Rosenblum joins ZEISS following more than eight years at Oticon, a division of Demant, where he served as President for US Hearing Aids and led efforts to bring the company’s life-changing hearing solutions to Americans with mild-to-severe hearing loss. Under his leadership, Oticon achieved outstanding results in terms of growing market share and increasing revenue, driven by new approaches in sales, talent development and transformation. Before that, Rosenblum led the Enterprise Customer Team at Johnson & Johnson, working with the largest hospital systems on the West Coast. He’s also served as Director, Global Strategic Marketing at Abbott, leading the charge in the worldwide commercialization of the company’s Diabetes Care portfolio.
Also Read: Emulate Launches AVA™ System to Speed Drug Development
“Gary’s hands-on experience in highly relevant healthcare roles and his proven track record of success make him an excellent fit to join the ZEISS Vision Care team,” said Sven Hermann, CEO ZEISS Consumer Markets. “With Gary at the helm, I am confident we will continue our positive momentum and maintain ZEISS’ leadership in the US market. I am incredibly grateful for the role Jens played in transforming ZEISS Vision Care in North America over the past ten years and wish him the best in his future endeavors.”
In his role as president and CEO, Rosenblum will focus on growing ZEISS Vision Care US, both in terms of the core business and future opportunities. Driven by a commitment to protect and improve eye health, he is passionate about continuing the legacy of innovation that has guided ZEISS for more than 179 years.
“I am thrilled to join ZEISS Vision Care and continue to build on the company’s mission of delivering industry-leading optical innovations to eyecare professionals and millions of Americans,” said Rosenblum. “I am already impressed with our incredible team in the US and their commitment to excellence. I’d like to thank Jens for his support with this transition and look forward to continuing his record of success for the company.”
Source: Businesswire